(Q44729971)

5 December 2017

title

FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes (English)

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

4 November 2022

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

4 November 2022

author name string

C. S. Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707760

4 November 2022

R. C. Boltz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707760

4 November 2022

J. J. Siekierka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707760

4 November 2022

N. H. Sigal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707760

4 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1707760

4 November 2022

publication date

1 April 1991

1 reference

full work available at URL

5 December 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:000887499190103I?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

https://api.elsevier.com/content/article/PII:000887499190103I?httpAccept=text/plain

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

4 November 2022

1 reference

5 December 2017

volume

133

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

269-284

1 reference

The effects of cyclosporin A on the immune system

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Studies of the effects of FK506 on renal allografting in the beagle dog.

4 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

4 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression

4 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells

4 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Highly purified human T-lymphocytes do not respond to mitogens--including calcium ionophore and phorbol ester

4 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity

4 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores

4 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

4 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation.

4 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies

4 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Cyclosporine does not prevent cytoplasmic calcium changes associated with lymphocyte activation.

4 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A

4 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Comparison of the immunosuppressive effects of cyclosporine, lipid-soluble anesthetics, and calmodulin antagonists. Response to exogenous interleukin 2.

4 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Suppression of B cell activation by cyclosporin A, FK506 and rapamycin

4 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.

4 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Dissociation of phosphoinositide hydrolysis and Ca2+ fluxes from the biological responses of a T-cell hybridoma

4 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway

4 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0008-8749(91)90103-I

4 November 2022

Identifiers

1 reference

5 December 2017

1 reference